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Methylation of H3-Lysine 79 Is Mediated by
a New Family of HMTases without a SET Domain
have been reported [6–14]. One common feature of
these histone lysine methyltransferases is that they all
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1349.72) is 14.03 Da heavier than the predicted massSummary
of an H3 tryptic peptide “EIAQDFKTDLR” corresponding
to amino acids 73–83. Such a mass difference couldThe N-terminal tails of core histones are subjected to
be a result of methylation (DeltaMass database: http://multiple covalent modifications, including acetylation,
www.abrf.org/index.cfm/dm.home). To explore thismethylation, and phosphorylation [1]. Similar to acet-
possibility, the two peptides with masses of 1335.69ylation, histone methylation has emerged as an impor-
and 1349.72 were subjected to tandem (MS/MS) masstant player in regulating chromatin dynamics and gene
spectrometric sequencing. Results shown in Figuresactivity [2–4]. Histone methylation occurs on arginine
1Ab and 1Ac unequivocally demonstrate that both pep-and lysine residues and is catalyzed by two families of
tides correspond to EIAQDFKTDLR and that the heavierproteins, the protein arginine methyltransferase family
peptide is monomethylated on K79 (Figures 1Ab andand the SET-domain-containing methyltransferase
1Ac).family [3]. Here, we report that lysine 79 (K79) of H3,
Based on the published nucleosome structure [15],located in the globular domain, can be methylated.
K79 is located in a loop connecting the first and theK79 methylation occurs in a variety of organisms rang-
second  helixes (Figure 1Ad). This region is exposeding from yeast to human. In budding yeast, K79 methyl-
and is adjacent to the interface between H3/H4 tetrameration is mediated by the silencing protein DOT1. Con-
and the H2A/H2B dimer. Although K79 is not directlysistent with conservation of K79 methylation, DOT1
involved in the formation of the interface, it is in a posi-homologs can be found in a variety of eukaryotic or-
tion capable of influencing the access to the interface,ganisms. We identified a human DOT1-like (DOT1L)
raising the possibility that methylation on K79 may playprotein and demonstrated that this protein possesses
an important role in regulating the access of proteinintrinsic H3-K79-specific histone methyltransferase
factors to chromatin.(HMTase) activity in vitro and in vivo. Furthermore, we
found that K79 methylation level is regulated through-
out the cell cycle. Thus, our studies reveal a new meth-
H3-K79 Methylation Is Conserved from Yeastylation site and define a novel family of histone lysine
to Humanmethyltransferase.
To confirm the above finding and to explore the possible
conservation of K79 methylation in other organisms, we
Results and Discussion generated a polyclonal antibody against a dimethyl-K79
H3 peptide “IAQDFmKTDLRF.” To examine the specific-
Identification of H3-K79 as a Novel ity of the antibody, recombinant histone H3 that is either
Methylation Site not methylated or methylated on K4 or K9 by SET7 [8]
Histone methylation has emerged as an important player or SUV39H1 [5], respectively, were subjected to Coo-
in regulating gene expression and chromatin function massie staining and Western blot analysis. As a positive
[2–4]. Histone methylation occurs on arginine and lysine control, equivalent amounts of core histones purified
residues at the N-terminal tails of histones H3 and H4 from HeLa cells were also analyzed. Results shown in
and is catalyzed by two distinct family of proteins, the Figure 1B demonstrate that while the antibody recog-
PRMT1 and the SET-domain-containing family of pro- nized histone H3 purified from HeLa cells, it did not
teins [3]. Since the discovery of the first histone lysine recognize unmethylated or K4- or K9-methylated H3
methyltransferase [5], other lysine methyltransferases (Figure 1B, bottom panel). In addition, competition with
that methylate histone H3 at lysines 4, 9, 27, and 36 two peptides of identical amino acid sequences with or
without dimethylation on K79 demonstrates that only
the methylated peptide is capable of abolishing the reac-4 Correspondence: yi_zhang@med.unc.edu
Figure 1. H3-K79 Methylation Is Conserved from Yeast to Human
(A) Identification of H3-K79 methylation. (Aa) MALDI-TOF MS of histone H3. HeLa histone H3 was digested with trypsin, and resulting peptides
were concentrated on a Poros 50 R2 (Perseptive Biosystems; Framingham, MA) reversed-phase micro-tip and analyzed by MALDI-reTOF MS
using a Reflex III instrument (Bruker Daltonics; Bremen, Germany), as described [8]. Only the relevant portion of the spectrum is shown.
Internal calibrants (6.25 fmoles each; “CAL”) and three prominent ions with predicted H3-peptide sequences are indicated. The ion with a
m/z value of 1349.72 is 14.03 Da heavier than the mass of “EIAQDFKTDLR.” (Ab and Ac) Nano-ES MS/MS. Tryptic digest mixtures were
analyzed by electrospray ionization (ESI) MS using an API 300 triple quadrupole instrument (Applied Biosystems/MDS SCIEX; Thornhill,
Canada), modified with a continuous-flow NanoES source, as described [25]. Precursor ions (m/z  668.4 in panel [Ab]; m/z  675.4 in [Ac]),
corresponding to doubly charged (z  2) versions of peptide ions marked “1335.69” and “1349.72” in panel (Aa), were selected for collision-
induced dissociation (CID)-based MS/MS analysis. Both fragment ion spectra were inspected for y″ ion series; deduced sequences are
indicated (note that y″ ion series originate at the C terminus and therefore read backward). (Ad) Location of K79 of histone H3 relative to the
two  helices (1 and 2) and loop 1 (L1) based on the published nucleosome structure [15].
(B) Characterization of the H3-mK79 antibody. HeLa core histones, recombinant histone H3 that are not methylated, methylated by SET7, or
SUV39 were analyzed by Coomassie staining and Western blots using the mK4-, mK9-, and mK79-specific antibodies. The mK79-specific
antibody was raised against a H3 peptide containing dimethylated K79 (IAQDFmKTDLRF).
(C) H3-K79 methylation occurs in a wide range of organisms. Equivalent amounts of histones, as evidenced by Coomassie staining, from
different organisms indicated on top of the panel were analyzed by Western blot using the H3-mK79-specific antibody.
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Figure 2. Identification of a Human DOT1-like Protein
(A) Alignment of the amino acid sequences of the DOT1 family proteins. Only the most conserved regions are shown. Sequences used in the
alignment include yeast DOT1 (NP_010728) and its homologs from human (AF509504), Drosophila (AAF54122), and C. elegans (NP_510056).
We note that four additional putative C. elegans proteins in GenBank (NP_509981, NP_490970, NP_509997, NP_508351) also show significant
homology to DOT1. Sequences predicted to be involved in SAM binding [17] are indicated. Numbers represent the amino acid number of
respective proteins. Gaps are indicated by “-”. Amino acids that are identical or have similar properties are shaded.
(B) Amino acid sequence of human DOT1L. Predicted SAM binding motifs are underlined. Mutation of the shaded amino acids abolished the
HMTase activity of hDOT1L.
tivity of the antibody toward the HeLa histone H3 (data clude that H3-K79 methylation is conserved from yeast
to human.not shown). Thus, we conclude that the antibody is H3-
mK79 specific.
The fact that K79 and adjacent sequences of H3 are Human DOT1-like Protein Is an H3-K79-Specific
conserved in different organisms prompted us to test Methyltransferase
the possibility of H3-K79 methylation occuring in other Having demonstrated that H3-K79 methylation occurs
organisms. Thus, core histones isolated from chicken, in yeast, we attempted to identify the responsible en-
Drosophila, and budding yeast were analyzed by West- zyme in this organism. With the H3-mK79-specific anti-
ern blotting using the H3-mK79-specific antibody. As body in hand, we decided to take a candidate approach.
negative and positive controls, recombinant H3 and We reasoned that deletion of the K79 HMTase should
HeLa core histones were included in the assay. Results lead to loss or reduction of K79 methylation that could be
shown in Figure 1C demonstrate that H3-K79 methyla- detected by Western blotting using the mK79-specific
antibody. The candidate genes that we screened includetion occurs in all the organisms analyzed. Thus, we con-
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Figure 3. hDOT1L Is a Nucleosomal H3-K79-Specific HMTase
(A) Recombinant hDOT1L is a nucleosomal H3-specific HMTase in vitro. About 0.2 g of different version of recombinant hDOT1L proteins
were incubated with 10 g of core histones or equivalent amounts of nucleosomes as described [8]. The reaction mixtures were resolved in
SDS-PAGE followed by Coomassie staining and fluorogram. Recombinant hDOT1L proteins shown in the top panel are 15-fold of what were
used in HMTase assay.
(B) hDOT1L methylates H3-K79 in vivo. Empty vector, as well as vectors that encode Flag-tagged wild-type or mutant hDOT1L were transfected
into 293T cells using the Qiagen Effectene Transfection Reagent. Two days after transfection, cells were collected for the preparation of total
cell lysates and histones. Expression of wild-type and mutant hDOT1L was verified by Western blots using anti-Flag antibody. Equal loading
of lysates was confirmed by probing for tubulin. Equal loading of histones was verified by Coomassie staining.
the six yeast SET domain-containing proteins (Set1 to tein sequences revealed no known functional motif other
than a putative SAM binding domain (Figure 2B).Set 6) as well as those that predicted to encode SAM
binding domain-containing proteins [16, 17]. This screen To determine whether hDOT1L possesses intrinsic
HMTase activity, two recombinant proteins correspond-resulted in the identification of DOT1 as the HMTase
responsible for K79 methylation in yeast [18]. ing to the N-terminal 351 and 472 amino acids of
hDOT1L, respectively, were produced in E. coli. The NDot1 was originally identified in a genetic screen for
genes whose overexpression disrupts telomeric silenc- terminus of hDOT1L was chosen because this region
contains the putative SAM binding motif and is mosting [19]. Disruption or overexpression of Dot1 not only
impaired telomeric silencing but also reduced silencing conserved among the different DOT1L proteins (Figure
2A). HMTase assays revealed neither protein possessesat mating type and rDNA loci [19]. In addition to partici-
pating in silencing, DOT1 also plays an important role significant enzymatic activity when free core histones
were used as substrates (Figure 3A, lanes 1–3). How-in meiotic checkpoint control [20]. Given that K79 meth-
ylation is conserved from yeast to human (Figure 1C), ever, when nucleosomes were used as substrates,
hDOT1L(1-472) exhibits significant HMTase activity, al-we expect that DOT1-like (DOT1L) proteins exist in other
organisms. A Blast search revealed several putative pro- though hDOT1L(1-351) is inactive (Figure 3A, lanes 4 and
5). To demonstrate that the HMTase activity depends onteins with significant sequence homology to DOT1. Se-
quence alignment of these proteins revealed several its ability to bind to SAM, we generated a mutated ver-
sion of hDOT1L(1-472) by changing the highly conservedconserved blocks (Figure 2A) that were predicted to be
involved in SAM binding [17]. The Blast search also GSG163-165 sequence within motif I (Figure 2A) to RCR.
This mutation completely abolished the HMTase activityrevealed that a hypothetical human protein (GenBank
accession number AAC08316) encoded by a gene lo- (Figure 3A, compare lanes 5 and 6). Taken together,
these results demonstrate that hDOT1L is a nucleosomalcated on 19p13.3 is likely the human DOT1L. However,
this hypothetical protein is incomplete at both 5 and 3 H3-specific HMTase and that both the SAM binding mo-
tif and the sequences between amino acids 351 and 472ends. To clone the full-length cDNA encoding hDOT1L,
several EST clones were obtained and sequenced. Two are critical for its enzymatic activity.
Having demonstrated the HMTase activity of humanoverlapping EST clones (BF507396 and BF982417) con-
tain a single open reading frame (ORF) which is pre- DOT1L in vitro, we attempted to demonstrate its
HMTase activity in vivo. To this end, mammalian expres-dicted to encode 1537 amino acids with a calculated
mass of 165 kDa (Figure 2B). The fact that the nucleotide sion vectors encoding a Flag-tagged hDOT1L and a
motif I mutant were transfected into 293T cells. Coresequence around the first methionine conforms to the
Kozak initiator sequence in combination with the fact histones purified from the transfected cells were ana-
lyzed by Coomassie and Western blotting using antibod-that the cDNA contains an upstream stop codon indicate
that the 1537 amino acids encoded by the cDNA repre- ies specific for methylated K4, K9, or K79. Results shown
in Figure 3B demonstrate that overexpression ofsent the full-length protein. Analysis of the hDOT1L pro-
Figure 4. H3-K79 Methylation Level Is Cell Cycle Regulated
(A) Cells released from double thymidine block were analyzed by flow cytometry. The numbers of cells (arbitrary units) were plotted against
DNA content.
(B) Cell extracts and histones derived from samples analyzed in (A) were analyzed by Western blots. SLBP and cyclin A were used as cell
cycle markers; tubulin was used as loading control. Equal loading of histones was revealed by Coomassie staining. The H3-K79 methylation
level was analyzed by probing with the mK79-specific antibodies. The cell cycle stage of each sample is indicated on top of the panel. “asy”
represents asynchronized cell extracts.
(C and D) Identical to (A and B) except that the cells were arrested at M phase before release.
(E) mK79 level in relation to cell DNA content. Cells were labeled with FITC-conjugated goat anti-rabbit secondary antibody in the absence
(left panel) or presence of primary antibody (middle and right panels) as indicated. DNA in each cell was labeled with PI. Each spot represents
an individual cell. The numbers represent arbitrary FITC unit. Unlabeled cells were analyzed by flow cytometry (left panel insert) to serve as
standard for DNA content. The intensity of FITC signal (measurement of Mi-2 or mK79) is plotted against PI signal (measurement of DNA
content that correlates with cell cycle stages). Arrowheads and arrows represent early S phase and late S phase, respectively.
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hDOT1L significantly increased H3-K79 methylation K79 methylation level and DNA content, respectively.
As expected, negative controls without a primary anti-while having no effect on K4 and K9 methylation (com-
pare lanes 1 and 2). The increased K79 methylation is body or with antibody against Mi-2, a component of a
nucleosome remodeling and deacetylase complex [24],dependent on an intact motif I as transfection of a motif
I mutant did not affect K79 methylation (compare lanes resulted in a slight increase in FITC signals when cells
go from G1 phase to G2/M phase (Figure 4E, left and1 and 3). This differential effect is not caused by differen-
tial expression, since both constructs expressed middle panels). This result is expected as cell size be-
comes bigger during this transition. However, labelinghDOT1L at a similar level (Figure 3B, bottom two panels).
Based on these results, we conclude that hDOT1L is an of the cells with the mK79-specific antibody resulted in
a decrease in FITC-labeling when cells go through SH3-K79-specific HMTase in vivo.
phase (Figure 4E, right panel, compare early and late S
phases). It is unlikely that the decrease in mK79 level
Methylation on K79 Is Regulated during S phase is caused by “dilution” by nascent his-
during the Cell Cycle tones during chromatin assembly, as similar decrease
Previous studies have demonstrated that the total his- is not observed in other methylation sites (data not
tone methylation level is regulated during the cell cycle shown). By using two different methods, we demon-
[21]. Thus, we asked whether K79 methylation level strate that the K79 methylation level decreases during
changes during the cell cycle. To obtain a population S phase, reaches its lowest level in G2, increases during
of synchronous cells, we arrested HeLa cells at the G1/S M phase, and maintains at a high level during G1 phase.
border using a double thymidine block. After releasing In this study, we present evidence that K79 within the
the arrested cells from the thymidine block, cells were globular domain of histone H3 is methylated and this
collected every 2 hr for flow cytometry as well as for modification is conserved from yeast to human (Figure
the preparation of protein extracts and histones. Flow 1). Based on the studies in yeast, we isolated a human
cytometry analysis (Figure 4A) indicated that more than DOT1 homolog and show that the human protein pos-
95% of the cells progress through S phase and enter sesses intrinsic HMTase activity toward K79 (Figure 3).
G2 synchronously. The cells were successfully arrested Thus, our studies establish that both the K79 methyla-
at the G1/S border before release, as evidenced by the tion and the responsible enzymes are evolutionarily con-
accumulation of the histone mRNA stem-loop-binding- served. Since DOT1 and its homologs do not contain a
protein (SLBP) (Figure 4B). As demonstrated previously SET domain, a signature motif present in all the known
[22], SLBP levels stayed high throughout S phase and histone lysine methyltransferases [3], the DOT1 family
dropped rapidly as cells exited S phase (Figure 4B). The of proteins represents a novel class of histone lysine
cells completed mitosis about 12 hr after release, as methyltransferase. What might be the function of K79
evidenced by the degradation of cyclin A when cells methylation? Previous studies indicate that DOT1 is in-
enter anaphase (Figure 4B). To determine whether K79 volved in telomere silencing [19] and meiotic checkpoint
methylation levels change during the cell cycle, histones control [20]. Consistent with its role in telomeric silenc-
isolated from corresponding cells were subjected to ing, deletion of Dot1 gene resulted in mislocalization of
Western blotting using the mK79-specific antibody. This the silencing protein Sir2 and Sir3 [20]. Mutations on H3-
analysis demonstrates that K79 methylation level de- K79 or SAM binding motif of DOT1 resulted in impaired
creases during S phase and reaches the lowest level in telomeric silencing [18], suggesting that Dot1 regulates
G2 and increases during M phase (Figure 4B). telomeric silencing predominantly through methylation
To study the K79 methylation status in G1 phase, we of H3-K79. Whether the function of DOT1 in meiotic
arrested the cells with thymidine, released them, and checkpoint control is also directly linked to the methyla-
then arrested them in mitosis with nocodazole. After tion of K79 remains to be determined. In addition, the
releasing from the nocodazole block, the cells progress observation that K79 methylation level changes during
through G1 to S phase synchronously (Figure 4C). The the mitotic cell cycle (Figure 4) raises the possibility that
cells completed mitosis 2 hr after release from the noco- this modification might also play an important role in
dazole block, as evidenced by the degradation of cyclin mitotic cell cycle. It is worth noting that K79 is reason-
A (Figure 4D). The cells then started to enter S phase ably close to both the N-terminal tail of H4 and the
about 10 hr after release, as evidenced by the accumula- C-terminal helix of H2B in the nucleosome structure [15].
tion of SLBP (Figure 4D). Western blot analysis of the It is known that H4 N-terminal tail is extensively modified.
histones from cells collected at different time points In addition, K120 in the H2B C-terminal helix is ubiquiti-
after the nocodazole release indicates that the K79 nated. Whether K79 methylation plays a role in regulat-
methylation remains at a high level throughout the G1 ing these modifications remains to be determined.
phase (Figure 4D).
To further confirm the cell cycle-dependent changes Supplementary Material
Supplementary Material including detailed Experimental Proce-in K79 methylation, we performed bivariate analysis of
dures can be found with this article online at http://images.cellpress.DNA content and mK79 level using a method similar to
com/supmat/supmatin.htm.that used in analyzing cell cycle-dependent changes of
cyclins using asynchronous cells [23]. For each individ-
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